Director, Silicon Flatirons Centers' Entrepreneurship Initiative
CEO of Dynamis Corporation
Founder, Gilt Groupe
VP of Research & Policy, Ewing Marion Kauffman Foundation
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
Medical College of Wisconsin director of research commercialization
Partner, Third Rock Ventures
Serial Entrepreneur and Investor
|
|
It’s time to catch up on the latest venture funding news in the Boston area, from blockchain tech to data analytics, to selling sports gear online. Read on for details.
—SidelineSwap, the Boston-based operator of an online sports gear marketplace, said... Read more »
When leaders at Exact Sciences discussed dealing with the adversity of cold weather and a “historically severe” flu season in early 2018, some industry observers predicted a potential break in the long growth streak of the Madison, WI-based company’s flagship product,... Read more »
[Updated 4/26/18, 2:20pm ET. See below.] The gene-editing technology CRISPR-Cas9 has captured the world’s attention with the possibility of fixing tough diseases and altering human traits. While experimental medicine, ethical worries, and an epic patent battle have attracted most... Read more »
[Updated 4/26/18, 3:30 pm. See below.] Boston-area technology companies have played dealmaker lately, with notable mergers and acquisitions in augmented reality, online news curation, tourism tech, education, and veterinary software. Read on for details.
—Boston-based advertising technology firm BuySellAds... Read more »
Dallas—Five years after founding the Dallas Entrepreneur Center, Trey Bowles is stepping down as its chief executive officer.
“What I love to do is starting, building, and growing things,” Bowles said in an interview. “The DEC is doing what... Read more »
Austin—Dosh, a fintech and advertising startup that gets consumers cash back on certain purchases, has raised a $44 million Series A round of funding from some big-name investors, including PayPal.
Dosh, founded in 2016, has had an active start to... Read more »
Michigan’s innovation community continues to pump out news at a steady clip. Here are some of the latest updates from around the state.
—Ann Arbor’s Genomenon, a startup focused on genomic search data, has struck a new partnership with Boston’s ... Read more »
Farmers spend a lot of time and money trying to keep insects from damaging their crops. But the U.S. military sees some of these bugs as potential friends, not foes. A government-funded research project is studying how to use insects to... Read more »
Doctor On Demand, a startup that provides telemedicine services to patients who are unable or unwilling to see a doctor in person, says it has raised a $74 million round of outside financing.
The new cash comes as the San... Read more »
The Facebook and Cambridge Analytica data scandal may be the most prominent controversy the social networking company has had, but Jason Calacanis appears to call Facebook the “dark side” of social media for more reasons than that.
Calacanis is an angel... Read more »
Austin—BigCommerce, which sells software to allow businesses to build and run online stores, announced Wednesday that it has raised $64 million in new funding.
The investment round was led by Goldman Sachs with participation from current investors General Catalyst, GGV... Read more »
Jennifer Fonstad and Theresia Gouw launched Aspect Ventures with their own money in February 2014—and have hardly looked back. “We closed our first investment that first week,” Fonstad says. The pair went on to make a number of investments that first... Read more »
Just a few years ago, there were no drugs available for patients with the rare genetic disease spinal muscular atrophy. Now two cutting-edge therapies look headed for a commercial battle, with each data and revenue update a key moment in the... Read more »
Levodopa, the gold-standard medicine for Parkinson’s disease, has helped millions of patients since the 1970s manage the neurodegenerative disease.
But there’s a caveat. Nothing is available that can slow or reverse the loss of brain cells, and what’s more, levodopa’s effects... Read more »
For all the hype surrounding the potential for blockchain systems to transform many industries, the technology has yet to have much of an impact on businesses. But 2018 is shaping up to be a critical year for the budding sector: more... Read more »
Savari, whose technology is designed to create a shared communications web among cars, personal devices, and roadway signals, announced today it has raised $12 million in a Series B fundraising round.
Santa Clara, CA-based Savari makes V2X technology—that is, software... Read more »
Upper Hand, the Indianapolis startup focused on sports management software and business services, announced earlier this month that it has snagged $1.5 million in Series A funding from Houston, TX-based Park Ten Capital.
Company co-founder and CEO Kevin MacCauley came... Read more »
Five months after a mishap involving a delivery truck thousands of miles away prompted the cancellation of a scheduled driverless shuttle demonstration in Madison, WI, people living in and around the city have another chance to experience the potential future of... Read more »
Houston—Texas political leaders, along with heads of the Texas Medical Center and its institutions, announced on Monday plans for a biotech-focused hub that could place Houston on the map of life sciences innovation centers.
The TMC Translational Research campus, or... Read more »
As new technologies give drug developers greater insight into protein biology, more biotech and pharma companies are now emboldened to pursue what have long been dismissed as undruggable targets—the 75-85 percent of all human proteins that are beyond the reach of... Read more »
Revolution Medicines emerged three years ago to develop drugs from products found in nature and said its lead prospect would be an antifungal compound.
Redwood City, CA-based Revolution is now focused on cancer and has raised $56 million to bring a... Read more »
Eli Lilly said enough to convince an FDA advisory panel that its experimental rheumatoid arthritis drug is effective in treating the inflammatory disorder. But on safety, the independent experts were not uniformly persuaded, and they voted to recommend approval only for... Read more »
Sponsored · Whitepaper
Understand who’s affected, what’s changed, and the impact on your business with the Labor Department's 'final rule' requirements for financial disclosures.
DocuSign
Sponsored · Whitepaper
Transitioning to electronic paperwork, contracts, and transactions.
DocuSign
Sponsored · Whitepaper
What preventative steps can deter bribery and corruption, and does the life sciences sector pose any particular challenges?
RSM
The Hidden Risks of Sourcing Human Biological Samples
Scientist.com
CEO and Co-Founder, Tamr
Professor, Michigan State University
Founder and Chairman, Sycamore Networks
Managing Director, DaggerBoard Advisors
Chairman, CEO, & Founder, Alexandria Real Estate Equities
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
